Vestnik dermatologii i venerologiiVestnik dermatologii i venerologiiВестник дерматологии и венерологии0042-46092313-6294Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov11010.25208/0042-4609-2015-91-1-92-98CLINICAL CASE REPORTSНАБЛЮДЕНИЕ ИЗ ПРАКТИКИSquamous cell carcinoma in a psoriasis patient after multiple courses of phototherapyПлоскоклеточный рак кожи у больного псориазом, получавшего многокурсовую фототерапиюZhilovaM. B.ЖиловаМ. Б.
Russian Federation
SmolyannikovaV. A.СмольянниковаВ. А.
Russian Federation
State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian FederationФГБУ «Государственный научный центр дерматовенерологии и косметологии» Минздрава России24022015911929824082017Copyright ©; 2015, Zhilova M.B., Smolyannikova V.A.Copyright ©; 2015, Жилова М.Б., Смольянникова В.А.2015Zhilova M.B., Smolyannikova V.A.Жилова М.Б., Смольянникова В.А.https://creativecommons.org/licenses/by/4.0https://vestnikdv.ru/jour/article/view/110

The authors present a clinical case study of squamous cell carcinoma in a psoriasis patient after 24 courses of phototherapy (22 courses of PUVA therapy and two courses of mid-wavelength ultraviolet therapy (311 nm)). The malignant neoplasm developed against the background of signs of a chronic photodamage of the skin: lentigo, actinic elastosis, diffuse hyperpigmentation, spotty skin pigmentation.

Представлено клиническое наблюдение случая развития плоскоклеточного рака кожи у больного псориазом после проведения 24 курсов фототерапии (22 курса ПУВА-терапии и 2 курса УФВ-311). Злокачественное новообразование развилось на фоне признаков хронического фотоповреждения кожи: лентиго, актинического эластоза, диффузной гиперпигментации, крапчатой пигментации кожи).

ПУВА-терапияУФВ-311фототерапияфотоповреждениеплоскоклеточный рак кожиPUVA therapymid-wavelength ultraviolet therapy (311 nm)phototherapyphotodamagesquamous cell carcinomaWeinberg A.S., Ogle C.A., Shim E.K. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg 2007; 33: 885-899.Vulf K., Jhonson R., Sуurmond D. Fitzpatrick,s Color atlas of clinical dermatology. Moskva, 2007: 338.Zlokachestvennye novoobrazovaniya V Rossii v 2012 godu (zabolevaemost' i smertnost'). Pod red. A.D. Kaprina, V.V. Starinskogo, G.V. Petrovoy. M., 2014: 4.Khismatullina Z.R. Neoplasms of the skin. Epidemiology, classification, diagnosis. Kreativnaya khirurgiya i onkologiya. 2010; 3: 69-73.Fitzpatrick,s Dermatology in General Medicine (Dermatologiya Fitspatrika v klinicheskoy praktike): Klaus Wolff, Lowell A. Goldsmith, Stephen I. Katz, Barbara A. Gilchrest, Amy S. Paller, David J. Leffell. In: Kubanovа A.A., Ivanov A.N., eds. BINOM; 2012; Vol. 2: 1124.Greinert R., Volkmer B., Henning S., Breitbart E.W., Greulich K.O., Cardoso M.C., Rapp A. UVA-induced DNA doublestrand breaks result from the repair of clustered oxidative DNA damages. Nucleic Acids Res 2012; 40: 10263-10273.Moyal D.D., Fourtanier A.M. Broad-spectrum sunscreens provide better protection from solar ultraviolet-simulated radiation and natural sunlight-induced immunosuppression in human beings. J Am Acad Dermatol 2008; 58: 149-154.Bruynzeel I., Bergman W., Hartevelt H.M. et al. "High single-dose" European PUVA regimen also causes an excess of non-melanoma skin cancer. Br J Dermatol 1991; 124: 49-55.Lindelo^f B., Sigurgeirsson B., Tegner E., Lar-koè O., Johannesson A. PUVA and cancer risk: the Swedish follow-up study. Br J Dermatol 1999; 141: 108-112. ЛитератураHannuksela-Svahn A., Pukkala E., Koulu L., Jans_en C.T., Karvonen J. Cancer incidence among Finnish psoriasis patients treated with 8- methoxypsoralen bath PUVA. J Am Acad Dermatol 1999; 1: 694-696.BruynzeelI I., Bergman W., Hartevelt H.M. et al. ‘High single-dose’ European PUVA regimen also causes an excess of non-melanoma skin cancer. Br J Dermatol 1991; 124: 49-55.Stern R.S., Laird N., Melski J., Parrish J.A., Fitzpatrick T.B., Bleich H.L.Cutaneous squamouscell carcinoma in patients treated with PUVA. Engl J Med 1984; 310: 1156-1161.Stern R.S., Lange R. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Derma-tol1988; 91: 120-124.Stern R.S. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study. N Engl J Med 1990; 322: 1093-1097.Stern R.S., Lunder E.J. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis. Archives Of Dermatology 1998 Dec; 134 (12): 1582-5.Stern R.S., Liebman E.J., Vakeva L. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of non-melanoma skin cancer. PUVA Follow-up Study. J Natl Cancer Inst 1998; 90: 1278-1284.Stern R.S. PUVA Follow-Up Study. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 2001; 44: 755-761.Stern R.S., Bagheri S., Nichols K. et al. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis. J Am Acad Dermatol 2002; 47: 33-39.Chuang T.Y., Heinrich L.A., Schultz M.D. et al. PUVA and skin cancer. A historical cohort study on 492 patients. J Am Acad Dermatol 1992; 26: 173-177.Berg D., Otley C.C. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47: 1-17.Martorell-Calatayud A., Sanmartin Jimenez O., Cruz Mojarrieta J., Guillén Barona C. Cutaneous squamous cell carcinoma: defining the high-risk variant. Actas Dermosifiliogr. 2013; 104: 367-79.Mullen J.T., Feng L., Xing Y., Mansfield P.F., Gershenwald J.E., Lee J.E., Ross M.I., Cormier J.N. Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol. 2006; 13: 902-9.Jennings L., Schmults C.D. Management of high-risk cutaneous squamous cell carcinoma. J Clin Aesthet Dermatol. 2010; 3: 39-4.Brash D.E. Roles of the transcription factor p53 in keratinocyte carcinomas. Br J Dermatol 2006; 154 Suppl 1: 8-10.Ratushny V., Gober M.D., Hick R., Ridky T.W., Seykora J.T. From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest 2012; 122: 464-472.Bastiaens M.T., ter Huurne J.A., Kielich C., Gruis N.A., Westendorp R.G., Vermeer B.J., Bavinck J.N. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet 2001; 68: 884-894.Pacifico A., Goldberg L.H., Peris K., Chimenti S., Leone G., Ananthaswamy H.N. Loss of CDKN2A and p14ARF expressionoccurs frequently in human nonmelanoma skin cancers. Br J Dermatol 2008; 158: 291-297.Wang N.J., Sanborn Z., Arnett K.L., Bayston L.J., Liao W., Proby C.M., Leigh I.M. Loss-of-func-tion mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci USA 2011; 108: 17761-17766.Parris C.N., Jezzard S., Silver A., MacKie R., McGregor J.M., Newbold R.F. Telomerase activity in melanoma and nonmelanoma skin cancer. Br J Cancer 1999; 79: 47-53.Feldman S.R., Fleischer A.B. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications. Cutis 2011; 87: 201-207.Bastiaens M.T., ter Huurne J.A., Kielich C., Gruis N.A., Westendorp R.G., Vermeer B.J., Bavinck J.N. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet 2001; 68: 884-894.Mullen J.T., Feng L., Xing Y., Mansfield P.F., Gershenwald J.E., Lee J.E., Ross M.I., Cormier J.N. Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol. 2006; 13: 902-9.Rowe D.E., Carroll R.J., Day C.L. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992; 26: 976-90.Enoch S., Miller D.R., Price P.E., Harding K.G. Early diagnosis is vital in the management of squamous cell carcinomas associated with chronic non healing ulcers: a case series and review of the literature. Int Wound J. 2004; 1: 165-75.Shlyakhtunov E.A., Gidranovich A.V., Lud N.G., Lud L.N., Kozhar V.L., Prokoshin A.V. Skin cancer: state of the problem. Vestnik Vitebskogo gosudarstvennogo meditsinskogo universiteta. 2014; 13 (3); 20-28.Gantsev Sh.Kh., Yusupov A.S. Squamous cell carcinoma of the skin. Prakticheskaya onkologiya 2012; 13 (2): 80-91Swanson N.A. Mohs surgery. Technique, indications, applications, and the future. Arch Dermatol. 1983; 119: 761-73.Veness M.J., Ong C., Cakir B., Morgan G. Squamous cell carcinoma of the lip. Patterns of relapse and outcome: Reporting the Westmead Hospital experience, 1980-1997. Australas Radiol 2001; 45: 195-9.Willey A., Mehta S., Lee P.K. Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy. Dermatol Surg. 2010; 36: 652-8.LeBoeuf N.R., Schmults C.D. Update on the management of high-risk squamous cell carcinoma. Semin Cutan Med Surg. 2011; 30: 26-34.Lebwohl M., Swanson N., Anderson L.L., Melgaard A., Xu Z., Berman B. Ingenol mebutate gel for actinic keratosis. N Engl J Med 2012; 366: 1010-9.Gaffney D.C., Soyer H.P., Simpson F. The epidermal growth factor receptor in squamous cell carcinoma: An emerging drug target. Australas J Dermatol 2014; 55: 24-34.Cassarino D.S., Derienzo D.P., Barr R.J. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification-part one. J Cutan Pathol 2006; 33: 191-206.Johnson W.C., Helwig E.B. Adenoid squamous cell carcinoma (adenoacanthoma): a clinico-pathologic study of 155 patients. Cancer 1966; 19: 1639-1650.Nappi O., Pettinato G., Wick M.R. Adenoid (acantholytic) squamous cell carcinoma of the skin. J Cutan Pathol. 1989; 16: 114-121.Schornagel J.H., Verweij J., de Mulder P.H., Cognetti F. Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study. J Clin Oncol 1995 Jul; 13 (7): 1649-55.Katz K.A., Marcil I., Stern R.S. et al. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen+ ultraviolet a light-treated psoriasis patients. J Invest Dermatol 2002; 118: 1038-1043.